MSK begins CAR T cell clinical trial for children with relapsed or treatment-resistant ALL

Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.



from The Medical News http://www.news-medical.net/news/20150412/MSK-begins-CAR-T-cell-clinical-trial-for-children-with-relapsed-or-treatment-resistant-ALL.aspx